Spots Global Cancer Trial Database for Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Efficacy and Safety Study of Abnoba Viscum F 20mg in Malignant Pleural Effusion Patients
Official Title: A Phase 3, Multi-Center, Single-Arm, Open-Label Study For The Safety And Efficacy Of Mistletoe Extract (AbnobaViscum® Injection) In Malignant Pleural Effusions
Study ID: NCT02191540
Conditions
Interventions
Study Description
Brief Summary: Phase 3, non-randomized, Multicenter, single arm study to assess efficacy and safety of Abnoba viscum F 20mg in patients with malignant pleural effusion
Detailed Description:
Keywords
Eligibility
Minimum Age: 20 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Chonnam National University Hwasun hospital, Hwasun gun, Jeolla Namdo, Korea, Republic of
Busan University Hospital, Busan, , Korea, Republic of
Ulsan University Hospital, Ulsan, , Korea, Republic of
Contact Details
Name: Kook Joo Na, MD
Affiliation: Chonnam National University Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Friedemann Schad, MD
Affiliation: FORSCHUNGSINSTITUT HAVELHOHE
Role: PRINCIPAL_INVESTIGATOR
Name: YongJik Lee, MD
Affiliation: Ulsan University Hospital
Role: PRINCIPAL_INVESTIGATOR
Name: Yeong Dae Kim, MD
Affiliation: Busan University Hospital
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
